147 related articles for article (PubMed ID: 34142941)
1. New-Onset Hypercalcemia After Renal Transplant: An Infectious Etiology Beyond Persistent Hyperparathyroidism.
Koymen G; Celtik A; Cinkooglu A; Toz S; Asci G; Arda B; Toz H; Erdinc M
Exp Clin Transplant; 2022 Jul; 20(7):691-694. PubMed ID: 34142941
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia associated with
Coche S; Cornet G; Morelle J; Labriola L; Kanaan N; Demoulin N
Acta Clin Belg; 2021 Feb; 76(1):75-78. PubMed ID: 31470765
[No Abstract] [Full Text] [Related]
3. Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.
Yau AA; Farouk SS
BMC Infect Dis; 2019 Aug; 19(1):739. PubMed ID: 31438872
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia and pneumocystis Pneumonia after kidney transplantation: report of an exceptional case and literature review.
Chatzikyrkou C; Clajus C; Haubitz M; Hafer C
Transpl Infect Dis; 2011 Oct; 13(5):496-500. PubMed ID: 21414118
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia and suppressed PTH levels in a renal transplant patient infected with Pneumocystis carinii.
Aguirre AR; Balbo BE; Ianhez LE; da Costa MC; Andrade L
Ren Fail; 2007; 29(4):513-6. PubMed ID: 17497478
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia.
Chen WC; Chang SC; Wu TH; Yang WC; Tarng DC
Am J Kidney Dis; 2002 Feb; 39(2):E8. PubMed ID: 11840399
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients.
Sutton W; Chen X; Patel P; Karzai S; Prescott JD; Segev DL; McAdams-DeMarco M; Mathur A
Surgery; 2022 Jan; 171(1):69-76. PubMed ID: 34266650
[TBL] [Abstract][Full Text] [Related]
8. Acute Kidney Injury Secondary to Hypercalcemia in a Kidney Transplant Patient With Pneumocystis jirovecii Pneumonia: A Case Report.
Mascia G; Argiolas D; Carta E; Michittu MB; Piredda GB
Transplant Proc; 2019; 51(1):220-222. PubMed ID: 30736974
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis jirovecii pneumonia with an atypical granulomatous response after kidney transplantation.
Ramalho J; Bacelar Marques ID; Aguirre AR; Pierrotti LC; de Paula FJ; Nahas WC; David-Neto E
Transpl Infect Dis; 2014 Apr; 16(2):315-9. PubMed ID: 24621124
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients.
Hamroun A; Lenain R; Bui Nguyen L; Chamley P; Loridant S; Neugebauer Y; Lionet A; Frimat M; Hazzan M
Sci Rep; 2019 Aug; 9(1):12508. PubMed ID: 31467367
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet.
Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD
J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
[TBL] [Abstract][Full Text] [Related]
13. Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others.
Moyses-Neto M; Garcia TMP; Nardin MEP; Muglia VA; Molina CAF; Romao EA
Braz J Med Biol Res; 2021; 54(6):e10558. PubMed ID: 33909856
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of a 3-Year Therapy With Cinacalcet in Persistent Hyperparathyroidism After Renal Transplant.
Rivelli GG; Lopes de Lima M; Mazzali M
Transplant Proc; 2020 Jun; 52(5):1284-1286. PubMed ID: 32204903
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis carinii pneumonia with hypercalcemia and suppressed parathyroid hormone levels in a renal transplant patient.
Hung YM
Transplantation; 2006 Feb; 81(4):639. PubMed ID: 16495820
[No Abstract] [Full Text] [Related]
16. Missed Opportunities to Diagnose and Treat Tertiary Hyperparathyroidism After Transplant.
Green RL; Karhadkar SS; Kuo LE
J Surg Res; 2023 Jul; 287():8-15. PubMed ID: 36857809
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V
Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
Nakamura M; Tanaka K; Marui Y; Tomikawa S
Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
[TBL] [Abstract][Full Text] [Related]
19. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice.
Muirhead N; Zaltman JS; Gill JS; Churchill DN; Poulin-Costello M; Mann V; Cole EH
Clin Transplant; 2014 Feb; 28(2):161-5. PubMed ID: 24329899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
